4Schwerther HA,Jackson WG,Tolan G.Association of low serum concentration of bilirubin with increased risk of coronary artery disease[J].Clin Chem,1994,40(1):18-23.
5Berg K. Lp(a) lipoproteinz an overview[J]. Chem Phys Lipids, 1994, (67-68) :9-16.
6Ambrose JA, Winters SL, Stern A, et al. Angiographic morphology andthe pathogenesis of unstable angina pectoris[J]. J Am Coil Cardiol, 1985,5(3) : 609-616.
7Levin DC, Fallon JT. Significance of the angiographic morphology of localized coronary stenosest histopathologic correlations[J ]. Circulation, 1982,66 (2) : 316-320.
8Seed M, Ayres KL, Humphries SE, et al. Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men[J]. Am J Med,2001,110(1) :22-27.
9Moiler CS, Byberg L, Sundstrom J,et al. T wave abnormalities, high body mass index,current smoking and high lipoprotein (a) levels predict the development of major abnormal Q/QS patterns 20 years later. A population-based study[J]. BMC CardiovascDisord,2006,6(1):10.
10Hartmann M, yon Birgelen C, Mintz GS, et al. Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries[J]. J Am Coll Cardiol,2006,48(3) :446-452.
1Serruys PW,Unger F,Sousa JE, et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease[J]. N Engl J Med, 2001,344 (15): 1117- 1124.
2Weintraub WS, Ghazzal ZM, Douglas JS Jr, et al. Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty[J]. Circulation, 1993,87 ( 3 ): 831-840.
3Elezi S,Kastrati A, Neumann FJ, et al. Vessel size and long- term outcome after coronary stent placement[J]. Circulation,1998,98(18):1875-1880.
4Kereiakes D, Linnemeier TJ, Baim DS, et al. Usefulness of stent length in predicting in-stem restenosis(the MULTI-LINK stent trials)[J]. Am J Cardiol,2000,86(3) :336-341.
5Gertler MM,Garn SM, Levins SA. Serum uric acid in relation to age and physique in health and in coronary heart disease[J]. Ann Intern Med, 1951,34(6) : 1421-1431.
6Inoue T, Hoshi K, Yaguchi t, et al. Serum levels of circulating adhesion molecules after coronary angioplasty[J]. Cardiology, 1999,91 (4):236-242.
7Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late resenosis after coronary angioplasty[J]. J Am Coll Cardiol, 1999,34(5):1512-1521.
8Moreno PR, Palacios IF, Leon MN, et al. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue[J]. Am J Cardiol, 1999,84 (4) : 462-466,A9.
9Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971- 1992. National Health and Nutrition Examination Survey[J]. JAMA,2000,283(18) :2404-2410.
10Savage MP, Fischman DL, Rake R, et al. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries. Stent Restenosis Study(STRESS)Investigators[J]. J Am Coll Cardiol,1998,31(2) :307-311.
